Sex differences in corticotropin-releasing factor receptor signaling and trafficking: potential role in female vulnerability to stress-related psychopathology

D A Bangasser, A Curtis, B A S Reyes, T T Bethea, I Parastatidis, H Ischiropoulos, E J Van Bockstaele, R J Valentino, D A Bangasser, A Curtis, B A S Reyes, T T Bethea, I Parastatidis, H Ischiropoulos, E J Van Bockstaele, R J Valentino

Abstract

Although the higher incidence of stress-related psychiatric disorders in females is well documented, its basis is unknown. Here, we show that the receptor for corticotropin-releasing factor (CRF), the neuropeptide that orchestrates the stress response, signals and is trafficked differently in female rats in a manner that could result in a greater response and decreased adaptation to stressors. Most cellular responses to CRF in the brain are mediated by CRF receptor (CRFr) association with the GTP-binding protein, G(s). Receptor immunoprecipitation studies revealed enhanced CRFr-G(s) coupling in cortical tissue of unstressed female rats. Previous stressor exposure abolished this sex difference by increasing CRFr-G(s) coupling selectively in males. These molecular results mirrored the effects of sex and stress on sensitivity of locus ceruleus (LC)-norepinephrine neurons to CRF. Differences in CRFr trafficking were also identified that could compromise stress adaptation in females. Specifically, stress-induced CRFr association with beta-arrestin2, an integral step in receptor internalization, occurred only in male rats. Immunoelectron microscopy confirmed that stress elicited CRFr internalization in LC neurons of male rats exclusively, consistent with reported electrophysiological evidence for stress-induced desensitization to CRF in males. Together, these studies identified two aspects of CRFr function, increased cellular signaling and compromised internalization, which render CRF-receptive neurons of females more sensitive to low levels of CRF and less adaptable to high levels of CRF. CRFr dysfunction in females may underlie their increased vulnerability to develop stress-related pathology, particularly that related to increased activity of the LC-norepinephrine system, such as depression or post-traumatic stress disorder.

Figures

Figure 1
Figure 1
The role of cAMP signaling in the sex- and stress-related differences in LC neuronal activation by CRF. (A-D) LC activation by local CRF after pretreatment with Rp-cAMP-S (600 ng in 120 nl, intra-LC) or ACSF (120 nl) is shown for unstressed male (n=5-8) and female rats (n=4-6) and male (n=6-8) and female rats 24 h after swim stress (n=4-6). Bars depict the average response to CRF following ACSF (black) or Rp-cAMP-S (dark gray). Light gray bars represent the cAMP-mediated component (calculated by taking the difference between the vehicle and Rp-cAMP-S treated groups). In the unstressed state, a relatively low CRF dose activated LC neurons in females only [t(6)=3.56, p<0.05], and this response was completely cAMP-dependent. For both males and females, neuronal responses to the higher dose (30 ng) were mediated by cAMP-dependent and independent processes [F(1,26)=12.88, p<0.05] . Swim stress changed the cAMP signaling profile in males {stress×dose×drug interaction [F(1,46)=4.45, p<0.05]}, but not in females [F(1,39)=1.87, p>0.05].
Figure 2
Figure 2
Sex- and stress-related differences in CRFr association with different G proteins. (A-C) Representative blots of immunoprecipitated CRFr (green, MW=52kD) from different groups and (A) the Gs protein (red, MW=48kDa), (B) the Go protein (red, MW=40kDa) and (C) the Gq/11 protein (red, MW=40kDa). So that the presentation in A, matched that in B and C, a lane containing the molecular weight marker that was between female and male samples on the same gel was deleted and the image of male samples that were to the right of this lane were moved to the left of female samples. (D-F) Graphs show the mean ratio of the integrated intensity of each band of G proteins to the corresponding band of CRFr from the same samples (n=4-6 determinations, pooled 3 rats per determination). CRFr-Gs coupling was greater in unstressed ovariectomized and intact females compared to unstressed males [F(5,26)=2.56, p<0.05, post-hocs p<0.05]. Stress increased coupling in males (p<0.05) to a level comparable to that of unstressed females (p>0.05), but had no further effect on females (regardless of hormonal status; p>0.05). There were no significant differences in coupling of the CRFr to Go [F(3,20)=0.55, p>0.05] or Gq/11 [F(3,12)=0.55, p>0.05] (top band quantified). Data are represented as the mean (±SEM). Number sign indicates sex difference under basal (unstressed) conditions (i.e., greater coupling in unstressed females vs. unstressed males; p<0.05). Asterisks indicate a significant stress-induced increase compared to the unstressed same sex control (p<0.05).
Figure 3
Figure 3
Sex differences in proteins involved in CRFr internalization processes. (A) Blots represent the phosphothreonine band (red), CRFr band (green) and the merged image (yellow) indicating that both label the same protein (i.e., phosphorylated CRFr , MW=52 kDa). Protein for this blot was collected 24 h after stressor exposure. (B1-3) Bar graphs show the mean ratio of phosphothreonine:CRFr for each condition from tissue collected immediately [F(3,12)=0.39, p>0.05], 1 h [F(3,20)=0.58, p>0.05]or 24 h [F(3,20)=0.66, p>0.05] post-stress (n=4-6 determinations, pooled 3 rats per determination). (C) The Western blot shows the β-arrestin2 band (MW = 54 kDa) and the CRFr band 24 h after stressor exposure or handling. (D1-3) Graphs illustrate the ratio of β–arrestin2:CRFr for rats sacrificed immediately [F(3,12)=0.52, p>0.05], 1 h [F(3,16)=4.74, p<0.05] or 24 h post-stress [F(5,30)=5.77, p<0.05] (n=4-6 determinations, pooled 3 rats per determination). At both 1 and 24 h after stress, β–arrestin2 association with the CRFr was significantly increased in males (p<0.05) but not in females (p>0.05). Cycling females were included for an additional comparison at the 24 h timepoint, and there was no statistically significant difference in CRFr-β-arrestin2 association between ovariectomized and cycling females in either the unstressed or stressed condition (p>0.05). Data are represented as the mean (±SEM). Asterisks indicate a significant effect of stress compared to unstressed same sex control (p<0.05).
Figure 4
Figure 4
Electron microscopic visualization of CRFr compartmentalization and stress-induced trafficking in LC dendrites. A-C are electron photomicrographs of sections through the LC. (A1) LC dendritic profile (d) in an unstressed male rat with immunogold-silver labeling for the CRFr along the plasma membrane (arrowheads). The dendrite receives synaptic contacts from axon terminals (t). (A2) Dendrite from a male rat 24 h following swim stress. CRFr labeling shifts from the plasma membrane to the cytoplasm. (B1) Dendrite from an unstressed female rat shows that CRFr is prominent in the cytoplasm. (B2) Dendrite from a female rat 24 h following swim stress shows that CRFr labeling shifts from the cytoplasm to the plasma membrane. (C1-2) TH-immunoperoxidase-labeled dendrites containing immunogold-silver labeling for CRFr (CRFr+TH) in a female control (C1) and a stressed rat (C2). Arrowheads point to CRFr on the plasma membrane in C2. Arrows point to immunoperoxidase reaction product. (D) Bar graph indicating the percentage of internalized receptors for each condition (n=3, mean per rat generated from at least 125 dendritic profiles). Unstressed females had a significantly greater percentage of cytoplasmic receptors than unstressed males [F(1,8)=45.3, p<0.05, post-hoc, p<0.05]. Swim stress increased the percentage of CRFr in cytoplasm in males rats (p<0.05). In contrast, swim stress decreased the percentage of cytoplasmic CRFr in females (p<0.05). Data are represented as the mean (± SEM). Number sign indicates sex difference under unstressed conditions (p<0.05). Asterisks indicate a significant effect of stress compared to the unstressed same sex control (p<0.05). Scale bars=500 nm (A-C).

References

    1. Kessler RC, McGonagle KA, Swartz M, Blazer DG, Nelson CB. Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence. J Affect Disord. 1993 Oct-Nov;29(2-3):85–96.
    1. Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry. 1995 Dec;52(12):1048–1060.
    1. Marcus SM, Young EA, Kerber KB, Kornstein S, Farabaugh AH, Mitchell J, et al. Gender differences in depression: findings from the STAR*D study. J Affect Disord. 2005 Aug;87(2-3):141–150.
    1. Ter Horst GJ, Wichmann R, Gerrits M, Westenbroek C, Lin Y. Sex differences in stress responses: focus on ovarian hormones. Physiol Behav. 2009 May 25;97(2):239–249.
    1. Young EA, Altemus M. Puberty, ovarian steroids, and stress. Ann N Y Acad Sci. 2004 Jun;1021:124–133.
    1. Young EA. Sex differences in response to exogenous corticosterone: a rat model of hypercortisolemia. Mol Psychiatry. 1996 Sep;1(4):313–319.
    1. Young EA, Ribeiro SC, Ye W. Sex differences in ACTH pulsatility following metyrapone blockade in patients with major depression. Psychoneuroendocrinology. 2007 Jun;32(5):503–507.
    1. Gold PW, Wong ML, Chrousos GP, Licinio J. Stress system abnormalities in melancholic and atypical depression: molecular, pathophysiological, and therapeutic implications. Mol Psychiatry. 1996 Sep;1(4):257–264.
    1. Smith MA, Kling MA, Whitfield HJ, Brandt HA, Demitrack MA, Geracioti TD, et al. Corticotropin-releasing hormone: from endocrinology to psychobiology. Horm Res. 1989;31(1-2):66–71.
    1. Gold PW, Chrousos GP. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol Psychiatry. 2002;7(3):254–275.
    1. Strohle A, Holsboer F. Stress responsive neurohormones in depression and anxiety. Pharmacopsychiatry. 2003 Nov;36(Suppl 3):S207–214.
    1. Vamvakopoulos NC, Chrousos GP. Evidence of direct estrogenic regulation of human corticotropin-releasing hormone gene expression. Potential implications for the sexual dimophism of the stress response and immune/inflammatory reaction. J Clin Invest. 1993 Oct;92(4):1896–1902.
    1. Vamvakopoulos NV. Sexual dimorphism of stress response and immune/inflammatory reaction: the corticotropin releasing hormone perspective. Mediators Inflamm. 1995;4(3):163–174.
    1. Vale W, Spiess J, Rivier C, Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science. 1981 Sep 18;213(4514):1394–1397.
    1. Bale TL, Vale WW. CRF and CRF receptors: role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol. 2004;44:525–557.
    1. Owens MJ, Nemeroff CB. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev. 1991 Dec;43(4):425–473.
    1. Van Bockstaele EJ, Colago EE, Valentino RJ. Corticotropin-releasing factor-containing axon terminals synapse onto catecholamine dendrites and may presynaptically modulate other afferents in the rostral pole of the nucleus locus coeruleus in the rat brain. J Comp Neurol. 1996 Jan 15;364(3):523–534.
    1. Van Bockstaele EJ, Colago EE, Valentino RJ. Amygdaloid corticotropin-releasing factor targets locus coeruleus dendrites: substrate for the co-ordination of emotional and cognitive limbs of the stress response. J Neuroendocrinol. 1998 Oct;10(10):743–757.
    1. Valentino RJ, Van Bockstaele E. Convergent regulation of locus coeruleus activity as an adaptive response to stress. Eur J Pharmacol. 2008 Apr 7;583(2-3):194–203.
    1. Aston-Jones G, Rajkowski J, Kubiak P, Valentino RJ, Shipley MT. Role of the locus coeruleus in emotional activation. Prog Brain Res. 1996;107:380–402.
    1. Page ME, Berridge CW, Foote SL, Valentino RJ. Corticotropin-releasing factor in the locus coeruleus mediates EEG activation associated with hypotensive stress. Neurosci Lett. 1993;164:81–84.
    1. Lechner SM, Curtis AL, Brons R, Valentino RJ. Locus coeruleus activation by colon distention: role of corticotropin-releasing factor and excitatory amino acids. Brain Res. 1997 May 9;756(1-2):114–124.
    1. Wong ML, Kling MA, Munson PJ, Listwak S, Licinio J, Prolo P, et al. Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):325–330.
    1. O'Donnell T, Hegadoren KM, Coupland NC. Noradrenergic mechanisms in the pathophysiology of post-traumatic stress disorder. Neuropsychobiology. 2004;50(4):273–283.
    1. Southwick SM, Bremner JD, Rasmusson A, Morgan CA, 3rd, Arnsten A, Charney DS. Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder. Biol Psychiatry. 1999 Nov 1;46(9):1192–1204.
    1. Curtis AL, Bethea T, Valentino RJ. Sexually dimorphic responses of the brain norepinephrine system to stress and corticotropin-releasing factor. Neuropsychopharmacology. 2006 Mar;31(3):544–554.
    1. Hillhouse EW, Grammatopoulos DK. The molecular mechanisms underlying the regulation of the biological activity of corticotropin-releasing hormone receptors: implications for physiology and pathophysiology. Endocr Rev. 2006 May;27(3):260–286.
    1. Teli T, Markovic D, Levine MA, Hillhouse EW, Grammatopoulos DK. Regulation of corticotropin-releasing hormone receptor type 1alpha signaling: structural determinants for G protein-coupled receptor kinase-mediated phosphorylation and agonist-mediated desensitization. Mol Endocrinol. 2005 Feb;19(2):474–490.
    1. Oakley RH, Olivares-Reyes JA, Hudson CC, Flores-Vega F, Dautzenberg FM, Hauger RL. Carboxyl-terminal and intracellular loop sites for CRF1 receptor phosphorylation and beta-arrestin-2 recruitment: a mechanism regulating stress and anxiety responses. Am J Physiol Regul Integr Comp Physiol. 2007 Jul;293(1):R209–222.
    1. Carr GV, Bangasser DA, Bethea T, Young M, Valentino RJ, Lucki I. Antidepressant-Like Effects of kappa-Opioid Receptor Antagonists in Wistar Kyoto Rats. Neuropsychopharmacology. 2009 Nov 18;
    1. Reyes BA, Fox K, Valentino RJ, Van Bockstaele EJ. Agonist-induced internalization of corticotropin-releasing factor receptors in noradrenergic neurons of the rat locus coeruleus. Eur J Neurosci. 2006 Jun;23(11):2991–2998.
    1. Reyes BA, Valentino RJ, Van Bockstaele EJ. Stress-induced intracellular trafficking of corticotropin-releasing factor receptors in rat locus coeruleus neurons. Endocrinology. 2008 Jan;149(1):122–130.
    1. Rominger DH, Rominger CM, Fitzgerald LW, Grzanna R, Largent BL, Zaczek R. Characterization of [125I]sauvagine binding to CRH2 receptors: membrane homogenate and autoradiographic studies. J Pharmacol Exp Ther. 1998 Jul;286(1):459–468.
    1. Chen FM, Bilezikjian LM, Perrin MH, Rivier J, Vale W. Corticotropin releasing factor receptor-mediated stimulation of adenylate cyclase activity in the rat brain. Brain Res. 1986 Aug 27;381(1):49–57.
    1. Battaglia G, Webster EL, De Souza EB. Characterization of corticotropin-releasing factor receptor-mediated adenylate cyclase activity in the rat central nervous system. Synapse. 1987;1(6):572–581.
    1. De Souza EB. Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders. Psychoneuroendocrinology. 1995;20(8):789–819.
    1. Van Pett K, Viau V, Bittencourt JC, Chan RK, Li HY, Arias C, et al. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol. 2000 Dec 11;428(2):191–212.
    1. Premont RT. Once and future signaling: G protein-coupled receptor kinase control of neuronal sensitivity. Neuromolecular Med. 2005;7(1-2):129–147.
    1. Krupnick JG, Benovic JL. The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Annu Rev Pharmacol Toxicol. 1998;38:289–319.
    1. Holmes KD, Babwah AV, Dale LB, Poulter MO, Ferguson SS. Differential regulation of corticotropin releasing factor 1alpha receptor endocytosis and trafficking by beta-arrestins and Rab GTPases. J Neurochem. 2006 Feb;96(4):934–949.
    1. Swaab DF, Bao AM, Lucassen PJ. The stress system in the human brain in depression and neurodegeneration. Ageing Res Rev. 2005 May;4(2):141–194.
    1. Frederiksen SO, Ekman R, Gottfries CG, Widerlov E, Jonsson S. Reduced concentrations of galanin, arginine vasopressin, neuropeptide Y and peptide YY in the temporal cortex but not in the hypothalamus of brains from schizophrenics. Acta Psychiatr Scand. 1991 Apr;83(4):273–277.
    1. Viau V, Bingham B, Davis J, Lee P, Wong M. Gender and puberty interact on the stress-induced activation of parvocellular neurosecretory neurons and corticotropin-releasing hormone messenger ribonucleic acid expression in the rat. Endocrinology. 2005 Jan;146(1):137–146.
    1. Iwasaki-Sekino A, Mano-Otagiri A, Ohata H, Yamauchi N, Shibasaki T. Gender differences in corticotropin and corticosterone secretion and corticotropin-releasing factor mRNA expression in the paraventricular nucleus of the hypothalamus and the central nucleus of the amygdala in response to footshock stress or psychological stress in rats. Psychoneuroendocrinology. 2009 Feb;34(2):226–237.
    1. Desbonnet L, Garrett L, Daly E, McDermott KW, Dinan TG. Sexually dimorphic effects of maternal separation stress on corticotrophin-releasing factor and vasopressin systems in the adult rat brain. Int J Dev Neurosci. 2008 May-Jun;26(3-4):259–268.
    1. Patchev VK, Hayashi S, Orikasa C, Almeida OF. Ontogeny of gender-specific responsiveness to stress and glucocorticoids in the rat and its determination by the neonatal gonadal steroid environment. Stress. 1999 Aug;3(1):41–54.
    1. Seale JV, Wood SA, Atkinson HC, Harbuz MS, Lightman SL. Postnatal masculinization alters the HPA axis phenotype in the adult female rat. J Physiol. 2005 Feb 15;563(Pt 1):265–274.
    1. van de Stolpe A, Slycke AJ, Reinders MO, Zomer AW, Goodenough S, Behl C, et al. Estrogen receptor (ER)-mediated transcriptional regulation of the human corticotropin-releasing hormone-binding protein promoter: differential effects of ERalpha and ERbeta. Mol Endocrinol. 2004 Dec;18(12):2908–2923.
    1. Bohler HC, Jr., Zoeller RT, King JC, Rubin BS, Weber R, Merriam GR. Corticotropin releasing hormone mRNA is elevated on the afternoon of proestrus in the parvocellular paraventricular nuclei of the female rat. Brain Res Mol Brain Res. 1990 Aug;8(3):259–262.
    1. Speert DB, SJ MC, Seasholtz AF. Sexually dimorphic expression of corticotropin-releasing hormone-binding protein in the mouse pituitary. Endocrinology. 2002 Dec;143(12):4730–4741.
    1. Jedema HP, Grace AA. Corticotropin-releasing hormone directly activates noradrenergic neurons of the locus ceruleus recorded in vitro. J Neurosci. 2004 Oct 27;24(43):9703–9713.
    1. Potter E, Sutton S, Donaldson C, Chen R, Perrin M, Lewis K, et al. Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):8777–8781.
    1. Grammatopoulos DK, Randeva HS, Levine MA, Kanellopoulou KA, Hillhouse EW. Rat cerebral cortex corticotropin-releasing hormone receptors: evidence for receptor coupling to multiple G-proteins. J Neurochem. 2001 Jan;76(2):509–519.
    1. Refojo D, Echenique C, Muller MB, Reul JM, Deussing JM, Wurst W, et al. Corticotropin-releasing hormone activates ERK1/2 MAPK in specific brain areas. Proc Natl Acad Sci U S A. 2005 Apr 26;102(17):6183–6188.
    1. Curtis AL, Pavcovich LA, Grigoriadis DE, Valentino RJ. Previous stress alters corticotropin-releasing factor neurotransmission in the locus coeruleus. Neuroscience. 1995 Mar;65(2):541–550.
    1. Valentino RJ, Van Bockstaele EJ. Functional interactions between stress neuromediator and the locus coeruleur-noradrenaline system. In: Steckler T, K N, editors. Handbook of Stress and the Brain. The Netherlands; Elsevier: 2005. pp. 465–486.
    1. Curtis AL, Pavcovich LA, Valentino RJ. Long-term regulation of locus ceruleus sensitivity to corticotropin-releasing factor by swim stress. J Pharmacol Exp Ther. 1999 Jun;289(3):1211–1219.
    1. Dalla C, Pitychoutis PM, Kokras N, Papadopoulou-Daifoti Z. Sex Differences in Animal Models of Depression and Antidepressant Response. Basic Clin Pharmacol Toxicol. 2009 Dec 30;
    1. Palanza P. Animal models of anxiety and depression: how are females different? Neurosci Biobehav Rev. 2001 May;25(3):219–233.
    1. Cryan JF, Mombereau C. In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice. Mol Psychiatry. 2004 Apr;9(4):326–357.
    1. Aston-Jones G, Rajkowski J, Cohen J. Locus coeruleus and regulation of behavioral flexibility and attention. Prog Brain Res. 2000;126:165–182.
    1. Aston-Jones G, Cohen JD. An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance. Annu Rev Neurosci. 2005;28:403–450.
    1. Berridge CW, Waterhouse BD. The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res Brain Res Rev. 2003 Apr;42(1):33–84.
    1. Nemeroff CB. The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions. Mol Psychiatry. 1996 Sep;1(4):336–342.

Source: PubMed

3
Subskrybuj